A class action lawsuit has been filed against Inspire Medical Systems Inc. on behalf of investors who suffered losses between August 6, 2024, and August 4, 2025. The complaint alleges that the company made false statements and concealed critical information regarding the launch of its new product, Inspire V. Specifically, it is claimed that demand for Inspire V was poor due to providers having surplus inventory and reluctance to adopt the new treatment. Additionally, the company allegedly failed to complete essential tasks for the launch, such as training and onboarding treatment centers, setting up IT systems, updating insurer claims software, and ensuring Medicare reimbursement was in place. These failures, which contradicted the company's public assurances of a successful launch, led to significant losses for investors.